No Data
No Data
LexaGene Holdings Files for Bankruptcy
LexaGene Holdings Inc. (OTCMKTS:LXXGF) Short Interest Update
LexaGene Holdings Inc. (OTCMKTS:LXXGF – Get Rating) was the target of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 152,500
Lexagene Holdings Inc. Brief: Up 21% Early Friday As BioPharma Engages It in Second Feasibility Study; LXG Cancels Plans to Reprice Meridian's Warrants
09:37 AM EST, 12/16/2022 (MT Newswires) -- Price: 0.17, Change: +0.03, Percent Change: +21.43
LexaGene Closes Secured Convertible Note Transaction
BEVERLY, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLa
LexaGene Holdings Proposes to Amend Warrants Terms
BEVERLY, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) ("LexaGene" or the "Company"), a molecular diagnostics company that has commercialized the MiQLa
LexaGene Enters Into Secured Convertible Note Agreement
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. BEVERLY, Mass., Oct. 24, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc.,
No Data